Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 72.28%
March 31, 2026 65.69%
December 31, 2025 65.91%
September 30, 2025 67.52%
June 30, 2025 69.84%
March 31, 2025 67.56%
December 31, 2024 63.58%
September 30, 2024 67.83%
June 30, 2024 68.81%
March 31, 2024 68.28%
December 31, 2023 68.38%
September 30, 2023 69.02%
June 30, 2023 70.38%
March 31, 2023 66.32%
December 31, 2022 70.35%
September 30, 2022 65.59%
June 30, 2022 62.94%
Date Value
March 31, 2022 60.73%
December 31, 2021 67.58%
September 30, 2021 60.13%
June 30, 2021 67.31%
March 31, 2021 58.96%
December 31, 2020 64.62%
September 30, 2020 61.87%
June 30, 2020 59.45%
March 31, 2020 59.04%
December 31, 2019 60.92%
September 30, 2019 65.54%
June 30, 2019 57.74%
March 31, 2019 54.39%
December 31, 2018 42.36%
September 30, 2018 61.80%
June 30, 2018 16.27%
March 31, 2018 13.40%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 57.05%
AngioDynamics, Inc. 56.00%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%
Baxter International, Inc. 33.55%

Gross Profit Margin (Quarterly) Related Metrics